|
TRIM13 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.038100E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.57970000003171E-06 |
| Normal-vs-Stage2 |
2.500000E-01 |
| Normal-vs-Stage3 |
8.139600E-01 |
| Normal-vs-Stage4 |
2.806200E-01 |
| Stage1-vs-Stage2 |
1.019000E-01 |
| Stage1-vs-Stage3 |
3.6770999999991E-05 |
| Stage1-vs-Stage4 |
4.28649999995034E-06 |
| Stage2-vs-Stage3 |
1.940180E-01 |
| Stage2-vs-Stage4 |
6.632000E-02 |
| Stage3-vs-Stage4 |
4.436600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.917500E-03 |
| Normal-vs-AfricanAmerican |
4.447600E-01 |
| Normal-vs-Asian |
1.364120E-02 |
| Caucasian-vs-AfricanAmerican |
4.543000E-01 |
| Caucasian-vs-Asian |
3.722800E-01 |
| AfricanAmerican-vs-Asian |
1.903000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.607820E-01 |
| Normal-vs-Female |
1.839380E-04 |
| Male-vs-Female |
4.158800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.087800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.769300E-04 |
| Normal-vs-Age(61-80Yrs) |
2.018800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.849600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.776800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.822600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.306600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.968410E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.524000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.290800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.359700E-03 |
| Normal-vs-Grade 2 |
2.72810000034873E-07 |
| Normal-vs-Grade 3 |
1.793610E-01 |
| Normal-vs-Grade 4 |
2.33779999999628E-05 |
| Grade 1-vs-Grade 2 |
1.721360E-01 |
| Grade 1-vs-Grade 3 |
2.923700E-03 |
| Grade 1-vs-Grade 4 |
1.22719999717802E-08 |
| Grade 2-vs-Grade 3 |
1.171320E-04 |
| Grade 2-vs-Grade 4 |
1.6251444634463E-12 |
| Grade 3-vs-Grade 4 |
5.68189999494706E-08 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.2410519540681E-14 |
| Normal-vs-ccB subtype |
3.032200E-02 |
| ccA subtype-vs-ccB subtype |
<1E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.095600E-02 |
| Normal-vs-N1 |
1.201170E-01 |
| N0-vs-N1 |
3.877900E-02 |
|
|
